Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proto-oncogenes II.

P Rosen1

  • 1Hasbrouck Laboratory, University of Massachusetts, Amherst 01003.

Medical Hypotheses
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Activated proto-oncogenes generally do not cause tumors, except for translocated proto-myc in transgenic mouse embryos, which can lead to faulty development and transformation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timeline to dysphagia resolution after endoscopic intervention of an interarytenoid defect based on Video Fluoroscopic Swallow Study dysphagia severity.

International journal of pediatric otorhinolaryngology·2023
Same author

Optimal timing and technique for endoscopic management of dysphagia in pediatric aerodigestive patients.

International journal of pediatric otorhinolaryngology·2021
Same author

Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).

Cancer chemotherapy and pharmacology·2014
Same author

Nonpinhole approximations for interactive rendering.

IEEE computer graphics and applications·2014
Same author

Expression of Adhesion Molecules on the Surface of Activated Platelets is Diminished by PGI(2)-analogues and an NO (EDRF)-Donor: A Comparison Between Platelets of Healthy and Diabetic Subjects.

Platelets·2010
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Proto-oncogenes are critical for normal cellular functions.
  • Dysregulation of proto-oncogenes can contribute to cancer development.
  • Existing literature suggests varied roles for activated proto-oncogenes in tumorigenesis.

Purpose of the Study:

  • To review and synthesize current literature on activated proto-oncogenes.
  • To determine the involvement of activated proto-oncogenes in tumor development.
  • To identify specific mechanisms and exceptions in proto-oncogene-mediated transformation.

Main Methods:

  • Comprehensive literature review of studies on proto-oncogenes.
  • Analysis of data concerning retroviral infections, translocations, and inherited cancers.

Related Experiment Videos

  • Evaluation of evidence linking proto-oncogene activation to tumor formation.

    • Main Results:

    • Activated proto-oncogenes are generally not implicated in tumor development.
    • A notable exception is the translocation of proto-myc, which can induce transformation.
    • This specific mechanism is observed in transgenic mouse embryos exhibiting developmental defects.

    Conclusions:

    • The role of activated proto-oncogenes in tumorigenesis is limited.
    • Translocated proto-myc represents a specific oncogenic pathway.
    • Faulty development in transgenic models highlights the oncogenic potential of specific proto-oncogene alterations.